Manel Esteller Badosa-rekin lankidetzan egindako argitalpenak (19)

2024

  1. PVR (CD155) epigenetic status mediates immunotherapy response in multiple myeloma

    Leukemia

2021

  1. Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease

    Nature Communications, Vol. 12, Núm. 1

2020

  1. Epigenetic loss of the transfer RNA-modifying enzyme TYW2 induces ribosome frameshifts in colon cancer

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 117, Núm. 34, pp. 20785-20793

2019

  1. Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program

    Acta Neuropathologica, Vol. 138, Núm. 6, pp. 1053-1074

  2. Epigenetic loss of the endoplasmic reticulum-associated degradation inhibitor SVIP induces cancer cell metabolic reprogramming

    JCI Insight, Vol. 4, Núm. 8

  3. The altered transcriptome and DNA methylation profiles of docetaxel resistance in breast cancer PDX models

    Molecular Cancer Research, Vol. 17, Núm. 10, pp. 2063-2076

  4. The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis

    The Lancet Respiratory Medicine, Vol. 6, Núm. 10, pp. 771-781

2014

  1. Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels

    Journal of Hematology and Oncology, Vol. 7, Núm. 1

2012

  1. A DNA methylation fingerprint of 1628 human samples

    Genome Research, Vol. 22, Núm. 2, pp. 407-419

2011

  1. Epigenetic activation of SOX11 in Lymphoid Neoplasms by Histone modifications

    PLoS ONE, Vol. 6, Núm. 6

  2. Long-range epigenetic silencing associates with deregulation of Ikaros targets in colorectal cancer cells

    Molecular Cancer Research, Vol. 9, Núm. 8, pp. 1139-1151

2010

  1. DNA methylation profiles and their relationship with cytogenetic status in adult acute myeloid leukemia

    PLoS ONE, Vol. 5, Núm. 8

2009

  1. Epigenetic signatures associated with different levels of differentiation potential in human stem cells

    PLoS ONE, Vol. 4, Núm. 11

  2. New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling

    Blood, Vol. 113, Núm. 11, pp. 2488-2497

2008

  1. BCR-ABL1-induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia

    British Journal of Haematology, Vol. 142, Núm. 4, pp. 571-582

  2. Epigenetic inactivation of the Groucho homologue gene TLE1 in hematologic malignancies

    Cancer Research, Vol. 68, Núm. 11, pp. 4116-4122

2005

  1. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

    Nature Genetics, Vol. 37, Núm. 4, pp. 391-400

2002

  1. Cancer epigenetics and methylation [3] (multiple letters)

    Science